United States · FDA National Drug Code directory

Respiforce F-HP

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
43857-0609_75a1aff8-435f-4367-a5d4-c0b3cba0e849
Product NDC
43857-0609
Form
LIQUID
Composition / generic term
Aconitum Napellus, Arsenicum Album, Belladonna, Bryonia (Alba), Eupatorium Perfoliatum, Ferrum Phosphoricum, Gelsemium Sempervirens
Labeler
BioActive Nutritional, Inc.
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start / end (source format)
20210723
Source listing expiry
20261231

Source-listed ingredients

  • ACONITUM NAPELLUS WHOLE — 30 [hp_X]/mL
  • ARSENIC TRIOXIDE — 30 [hp_X]/mL
  • ATROPA BELLADONNA — 30 [hp_X]/mL
  • BRYONIA ALBA ROOT — 30 [hp_X]/mL
  • EUPATORIUM PERFOLIATUM FLOWERING TOP — 30 [hp_X]/mL
  • FERROSOFERRIC PHOSPHATE — 30 [hp_X]/mL
  • GELSEMIUM SEMPERVIRENS ROOT — 30 [hp_X]/mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 mL in 1 BOTTLE, DROPPER (43857-0609-1) · 43857-0609-1

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →